price
RE
NASDAQ · REPL
Replimune Group, Inc.
Healthcare · Biotechnology
$13.45
Down-$0.57 (-4.26%)
Updated Oct 2, 2026, 6:03 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 774.6M
- P/E ratio
- -3.23
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $16.33
- Volume
- 2.52M
- Avg. volume
- 5.08M
Price performance · REPL
REPL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
REPL closed at $13.45 after 20 trading sessions, down 12.03% for the selected period.
- Last close
- $13.45
- Period change
- -12.03%
- Period low
- $12.36
- Period high
- $15.29
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $13.26 | $13.59 | $13.055 | $13.45 | 2.52M |
| Sep 30, 2026 | $12.99 | $13.658 | $12.65 | $13.24 | 3.08M |
| Sep 29, 2026 | $12.44 | $13.42 | $12.35 | $13.00 | 4.37M |
| Sep 28, 2026 | $12.15 | $12.7572 | $12.07 | $12.56 | 1.97M |
| Sep 25, 2026 | $12.63 | $12.80 | $12.30 | $12.36 | 1.65M |
| Sep 24, 2026 | $12.87 | $12.8795 | $12.07 | $12.60 | 2.58M |
| Sep 23, 2026 | $13.50 | $13.60 | $12.68 | $12.96 | 1.89M |
| Sep 22, 2026 | $12.93 | $13.635 | $12.80 | $13.47 | 1.53M |
| Sep 21, 2026 | $13.11 | $13.28 | $12.76 | $12.87 | 1.46M |
| Sep 18, 2026 | $13.02 | $13.20 | $12.68 | $13.07 | 2.15M |
| Sep 17, 2026 | $13.15 | $13.3972 | $12.62 | $12.87 | 1.3M |
| Sep 16, 2026 | $13.10 | $13.19 | $12.7107 | $12.96 | 1.81M |
| Sep 15, 2026 | $12.98 | $13.06 | $12.46 | $13.03 | 2.15M |
| Sep 14, 2026 | $12.90 | $13.645 | $12.79 | $13.11 | 2.35M |
| Sep 11, 2026 | $13.33 | $13.74 | $12.40 | $12.92 | 4.09M |
| Sep 10, 2026 | $14.47 | $14.47 | $13.21 | $13.24 | 3.65M |
| Sep 9, 2026 | $14.54 | $14.76 | $14.30 | $14.45 | 1.07M |
| Sep 8, 2026 | $14.90 | $14.99 | $14.61 | $14.77 | 1.5M |
| Sep 4, 2026 | $15.22 | $15.3313 | $14.80 | $15.04 | 910.23K |
| Sep 3, 2026 | $15.99 | $16.025 | $15.02 | $15.29 | 1.35M |
Latest REPL news
The latest Smart Investors Daily articles mentioning REPL.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

